Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (186133) 186133
Journal Article (172738) 172738
Newspaper Article (9326) 9326
Newsletter (1847) 1847
Book Chapter (1355) 1355
Magazine Article (696) 696
Book / eBook (352) 352
Trade Publication Article (225) 225
Web Resource (174) 174
Conference Proceeding (137) 137
Dissertation (92) 92
Publication (53) 53
Transcript (51) 51
Government Document (27) 27
Reference (20) 20
Book Review (13) 13
Report (8) 8
Streaming Video (4) 4
Journal / eJournal (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (196057) 196057
biochemistry (194932) 194932
microbiology (193810) 193810
enzymology (187741) 187741
wine (186202) 186202
beer (186182) 186182
vinegar (186153) 186153
metallurgy (186140) 186140
mutation or genetic engineering (186133) 186133
spirits (186133) 186133
human necessities (175834) 175834
hygiene (174879) 174879
medical or veterinary science (174803) 174803
preparations for medical, dental, or toilet purposes (170928) 170928
culture media (163690) 163690
compositions thereof (163382) 163382
microorganisms or enzymes (163382) 163382
propagating, preserving or maintaining microorganisms (163382) 163382
specific therapeutic activity of chemical compounds ormedicinal preparations (154715) 154715
science & technology (133183) 133183
organic chemistry (127349) 127349
life sciences & biomedicine (117896) 117896
peptides (112820) 112820
humans (103855) 103855
enzymes (72593) 72593
animals (63191) 63191
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (56154) 56154
male (54740) 54740
physics (53581) 53581
testing (52576) 52576
measuring (52188) 52188
investigating or analysing materials by determining theirchemical or physical properties (52053) 52053
compositions or test papers therefor (48238) 48238
condition-responsive control in microbiological orenzymological processes (48238) 48238
measuring or testing processes involving enzymes, nucleicacids or microorganisms (48238) 48238
processes of preparing such compositions (48238) 48238
female (45320) 45320
biological and medical sciences (35887) 35887
medical sciences (30261) 30261
enzyme-linked immunosorbent assay (29466) 29466
proteins (26933) 26933
middle aged (25247) 25247
processes using microorganisms (24925) 24925
pharmacology & pharmacy (24649) 24649
mice (24068) 24068
adult (21817) 21817
nucleic acids (20747) 20747
derivatives thereof (20580) 20580
sugars (20390) 20390
nucleotides (20195) 20195
nucleosides (19920) 19920
research (18986) 18986
angiotensin-converting enzyme inhibitors - therapeutic use (18694) 18694
analysis (18624) 18624
aged (18525) 18525
rats (18155) 18155
enzyme inhibitors - pharmacology (16501) 16501
research article (16446) 16446
biochemistry & molecular biology (15929) 15929
oncology (15832) 15832
health aspects (15517) 15517
agriculture (15204) 15204
medicine (14873) 14873
gene expression (14546) 14546
forestry (14479) 14479
animal husbandry (14458) 14458
fishing (14452) 14452
trapping (14450) 14450
hunting (14437) 14437
enzyme inhibitors - therapeutic use (14177) 14177
pharmacology. drug treatments (14110) 14110
cancer (14024) 14024
science & technology - other topics (13861) 13861
physiological aspects (13154) 13154
cell biology (13095) 13095
multidisciplinary sciences (13023) 13023
apoptosis (12467) 12467
immunology (11867) 11867
rodents (11759) 11759
care and treatment (11555) 11555
inflammation (11369) 11369
abridged index medicus (11328) 11328
metabolism (11152) 11152
heterocyclic compounds (10955) 10955
studies (10837) 10837
science (10780) 10780
kinases (10421) 10421
cardiovascular system & cardiology (10172) 10172
treatment outcome (10005) 10005
medicine, research & experimental (9623) 9623
research & experimental medicine (9614) 9614
foods or foodstuffs (9502) 9502
their treatment, not covered by other classes (9502) 9502
care of birds, fishes, insects (9432) 9432
new breeds of animals (9432) 9432
rearing or breeding animals, not otherwise provided for (9432) 9432
neurosciences & neurology (9342) 9342
neurosciences (9086) 9086
tumors (9086) 9086
oxidative stress (9022) 9022
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (172) 172
Online Resources - Online (39) 39
Collection Dvlpm't (Acquisitions) - Vendor file (37) 37
Chemistry (A D Allen) - Stacks (24) 24
UofT at Mississauga - Stacks (18) 18
Collection Dvlpm't (Acquisitions) - Closed Orders (15) 15
Engineering & Comp. Sci. - Stacks (9) 9
UofT at Scarborough - Stacks (7) 7
UTL at Downsview - May be requested (3) 3
Robarts - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Theses (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (343511) 343511
French (63944) 63944
German (33165) 33165
Chinese (12298) 12298
Japanese (9982) 9982
Spanish (5748) 5748
Korean (4906) 4906
Portuguese (3406) 3406
Russian (2823) 2823
Danish (1979) 1979
Polish (1319) 1319
Norwegian (1310) 1310
Finnish (917) 917
Hungarian (887) 887
Czech (750) 750
Swedish (624) 624
Slovenian (450) 450
Italian (413) 413
Hebrew (391) 391
Slovak (272) 272
Ukrainian (256) 256
Greek (247) 247
Dutch (236) 236
Croatian (230) 230
Turkish (188) 188
Bulgarian (170) 170
Serbian (164) 164
Lithuanian (152) 152
Estonian (123) 123
Icelandic (80) 80
Romanian (73) 73
Indonesian (42) 42
Arabic (22) 22
Latvian (20) 20
Bosnian (12) 12
Persian (4) 4
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
by Sanders, James M and Monogue, Marguerite L and Jodlowski, Tomasz Z and Cutrell, James B
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2020, Volume 323, Issue 18, pp. 1824 - 1836
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxychloroquine - therapeutic use | Alanine - therapeutic use | Pandemics | Oseltamivir - therapeutic use | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Pyrazines - therapeutic use | Adrenal Cortex Hormones - therapeutic use | COVID-19 | Alanine - analogs & derivatives | SARS-CoV-2 | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Betacoronavirus - physiology | Ritonavir - therapeutic use | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Betacoronavirus - drug effects | Chloroquine - therapeutic use | Amides - therapeutic use | Withholding Treatment | Adenosine Monophosphate - therapeutic use | Azithromycin - therapeutic use | Adenosine Monophosphate - analogs & derivatives | Indoles - therapeutic use | Lopinavir - therapeutic use | Immunoglobulins - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Immunologic Factors - therapeutic use | Corticoids | Angiotensin-converting enzyme inhibitors | Corticosteroids | Medical treatment | Severe acute respiratory syndrome | Viral diseases | Clinical trials | Viruses | Coronaviruses | FDA approval | Severe acute respiratory syndrome coronavirus 2 | Oseltamivir | Enzyme inhibitors | Peptidyl-dipeptidase A | Influenza | Respiratory diseases | Angiotensin | Public health
Journal Article
Details down arrow
2. Full Text Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database
by Cronin-Fenton, Deirdre and Lash, Timothy L and Ahern, Thomas P and Damkier, Per and Christiansen, Peer and Ejlertsen, Bent and Sørensen, Henrik T
Acta oncologica, ISSN 0284-186X, 01/2018, Volume 57, Issue 1, pp. 120 - 128
Life Sciences & Biomedicine | Oncology | Science & Technology | Simvastatin - therapeutic use | Glucocorticoids - therapeutic use | Prognosis | Humans | Neoplasm Recurrence, Local | Serotonin Uptake Inhibitors - therapeutic use | Analgesics, Opioid - therapeutic use | Disease Progression | Cardiotonic Agents - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Estrogen Antagonists - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Breast Neoplasms - pathology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Cyclooxygenase 2 Inhibitors - therapeutic use | Denmark | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Databases, Factual | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
by Yusuf, Salim, Prof and Islam, Shofiqul, MSc and Chow, Clara K, PhD and Rangarajan, Sumathy, MSc and Dagenais, Gilles, Prof and Diaz, Rafael, MD and Gupta, Rajeev, PhD and Kelishadi, Roya, Prof and Iqbal, Romaina, PhD and Avezum, Alvaro, MD and Kruger, Annamarie, Prof and Kutty, Raman, Prof and Lanas, Fernando, MD and Lisheng, Liu, Prof and Wei, Li, Prof and Lopez-Jaramillo, Patricio, Prof and Oguz, Aytekin, MD and Rahman, Omar, Prof and Swidan, Hany, MD and Yusoff, Khalid, Prof and Zatonski, Witold, Prof and Rosengren, Annika, Prof and Teo, Koon K, Prof and on behalf of the Prospective Urban Rural Epidemiology (PURE) Study Investigators and PURE Study Investigators and Prospective Urban Rural Epidemiology (PURE) Study Investigators and Sahlgrenska akademin and Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin and Institute of Medicine, Department of Emergeny and Cardiovascular Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Miscellaneous | Biological and medical sciences | Medical sciences | Epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Current status of potential therapeutic candidates for the COVID-19 crisis
by Zhang, Jiancheng and Xie, Bing and Hashimoto, Kenji
Brain, behavior, and immunity, ISSN 0889-1591, 07/2020, Volume 87, pp. 59 - 73
Antiviral: Chinese traditional medicine | COVID-19 | Immunoenhancer | ACE2 blocker | Antimalaria | Vaccine | Monoclonal antibody | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Coronavirus Infections - prevention & control | Hydroxychloroquine - therapeutic use | Bevacizumab - therapeutic use | Killer Cells, Natural | Pandemics | Viral Vaccines - therapeutic use | Coronavirus Infections - drug therapy | Humans | Trace Elements - therapeutic use | Interferons - therapeutic use | Nitric Oxide - therapeutic use | Adrenal Cortex Hormones - therapeutic use | SARS-CoV-2 | Betacoronavirus | Antibodies, Monoclonal, Humanized - therapeutic use | Medicine, Chinese Traditional | Antiviral Agents - therapeutic use | Pneumonia, Viral - therapy | Anticoagulants - therapeutic use | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Peptidyl-Dipeptidase A | Vitamins - therapeutic use | Zinc - therapeutic use | Spike Glycoprotein, Coronavirus | Angiotensin-Converting Enzyme 2 | Immunoglobulins, Intravenous - therapeutic use | Janus Kinase Inhibitors - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | COVID-19 Vaccines | Coronavirus Infections - therapy | Immunization, Passive | Mesenchymal Stem Cell Transplantation | Immunologic Factors - therapeutic use | Virus diseases | Epidemics | Medical colleges | Antiviral agents | Medical research | Biological products | World health | Monoclonal antibodies | Medicine, Experimental | Medicine, Chinese | Coronaviruses | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Drug treatment of idiopathic pulmonary fibrosis systematic review and network meta-analysis
by Canestaro, William J and Forrester, Sara H and Raghu, Ganesh and Ho, Lawrence and Devine, Beth E
Chest, ISSN 0012-3692, 03/2016, Volume 149, Issue 3, pp. 756 - 766
Epidemiology (pulmonary) | Evidence-based medicine | Idiopathic pulmonary fibrosis | Meta-analysis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Recombinant Proteins - therapeutic use | Azathioprine - therapeutic use | Interferon-gamma - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anticoagulants - therapeutic use | Enzyme Inhibitors - therapeutic use | Warfarin - therapeutic use | Vital Capacity | Imatinib Mesylate - therapeutic use | Phenylpropionates - therapeutic use | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pyrimidines - therapeutic use | Bayes Theorem | Indoles - therapeutic use | Free Radical Scavengers - therapeutic use | Pyridones - therapeutic use | Acetylcysteine - therapeutic use | Endothelin Receptor Antagonists - therapeutic use | Idiopathic Pulmonary Fibrosis - drug therapy | Pyridazines - therapeutic use | Etanercept - therapeutic use | Treatment outcome | Usage | Pulmonary fibrosis | Drug therapy | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF)
by Raj, Leah and Adhyaru, Bhavin
Postgraduate medical journal, ISSN 0032-5473, 12/2016, Volume 92, Issue 1094, pp. 726 - 734
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Vasodilator Agents - therapeutic use | Erythropoietin - therapeutic use | United States | Humans | Calcium Channel Blockers - therapeutic use | Heart Failure - physiopathology | Aminobutyrates - therapeutic use | Cardiotonic Agents - therapeutic use | Societies, Medical | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Isosorbide Dinitrate - therapeutic use | Cardiology | Platelet Aggregation Inhibitors - therapeutic use | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hematinics - therapeutic use | Fumarates - therapeutic use | Anticoagulants - therapeutic use | Amides - therapeutic use | Antihypertensive Agents - therapeutic use | Evidence-Based Medicine | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | American Heart Association | Stroke Volume | Cardiovascular Agents - therapeutic use | Hydralazine - therapeutic use | Atrial Natriuretic Factor - therapeutic use | Iron - therapeutic use | Benzazepines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Peptide Fragments - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Practice Guidelines as Topic | Heart failure | Care and treatment | Usage | Analysis | Americans | Diagnosis | Cardiac output | Health aspects | Evidence-based medicine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights